Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Survival of patients following secondary cytoreductive surgery in ovarian cancer.

× No keyword cloud information.

23 in total

1. The role of secondary cytoreductive surgery in patients with recurrent epithelial ovarian, tubal, and peritoneal cancers: a comparative effectiveness analysis.

Authors: Chi-Mu Chuang; Yiing-Jeng Chou; Ming-Shyen Yen; Kuan-Chong Chao; Nae-Fang Twu; Hua-Hsi Wu; Kuo-Chang Wen; Yi-Jen Chen; Peng-Hui Wang; Chung-Ru Lai; Pesus Chou
Journal: Oncologist Date: 2012-05-16

2. A CA125 score as a prognostic index in patients with ovarian cancer.

Authors: A Rosen; P Sevelda; M Klein; J Spona; A Beck
Journal: Arch Gynecol Obstet Date: 1990 Impact factor: 2.344

3. Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.

Authors: W Jäger; R Adam; L Wildt; N Lang
Journal: Arch Gynecol Obstet Date: 1988 Impact factor: 2.344

4. The value of second-look operation in patients with advanced epithelial ovarian carcinoma.

Authors: P Sevelda; C Dittrich; H Salzer
Journal: Arch Gynecol Obstet Date: 1989 Impact factor: 2.344

5. Upper Abdominal Resections as Part of Tertiary Cytoreduction for Relapsed Ovarian Cancer.

Authors: Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Iulian Brezean
Journal: In Vivo Date: 2020 Jan-Feb Impact factor: 2.155

6. Maximal cytoreductive effort in epithelial ovarian cancer surgery.

Authors: Karin K Shih; Dennis S Chi
Journal: J Gynecol Oncol Date: 2010-06-30 Impact factor: 4.401

7. Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population.

Authors: Rani Akhil Bhat; Yin Nin Chia; Yong Kuei Lim; Kwai Lam Yam; Cindy Lim; Melissa Teo
Journal: Oman Med J Date: 2015-09

Review 8. Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Authors: Filippo Bellati; Chiara Napoletano; Ilary Ruscito; Maria Pastore; Milena Pernice; Morena Antonilli; Marianna Nuti; Pierluigi Benedetti Panici
Journal: Invest New Drugs Date: 2009-11-24 Impact factor: 3.850

9. Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer.

Authors: Dae Chul Jung; Sokbom Kang; Min Ju Kim; Sang Yoon Park; Hyun Beom Kim
Journal: Eur Radiol Date: 2009-08-06 Impact factor: 5.315

10. When should surgical cytoreduction in advanced ovarian cancer take place?

Authors: Igor E Martinek; Sean Kehoe
Journal: J Oncol Date: 2009-10-25 Impact factor: 4.375